A virtual reality counterconditioning procedure to reduce methamphetamine cue-induced craving

J Psychiatr Res. 2019 Sep:116:88-94. doi: 10.1016/j.jpsychires.2019.06.007. Epub 2019 Jun 14.

Abstract

The present work developed a virtual reality (VR) counterconditioning procedure (VRCP), and investigated its efficacy in treatment of cue-induced craving in individuals with methamphetamine (METH) dependence. In study 1, thirty-one patients diagnosed with METH dependence received VRCP, while twenty-nine METH-dependent patients in waiting-list group did not. In study 2, the VRCP was computerized as a VR treatment system. Six-hundred and twelve abstinent individuals with a history of METH dependence received the computerized VRCP, while two-hundred seventy-six abstinent individuals with a history of METH dependence in waiting-list group did not. Patients with METH dependence who received VRCP showed a significantly larger decrease on the score of METH-craving and METH-liking from baseline to follow-up assessments, compared to those who did not received VRCP. Participants received VRCP showed a significantly larger decrease in HRV indexes on time domain and non-linear domain from baseline to follow-up assessments during exposure to VR cues, compared to those in waiting-list group. These findings indicate that the counterconditioning procedure under VR environment may be a useful strategy in suppressing cue-induced reactivity for patients with METH dependence.

Keywords: Counterconditioning; Craving; Heart rate variability; Methamphetamine; Virtual reality.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amphetamine-Related Disorders / physiopathology*
  • Amphetamine-Related Disorders / therapy*
  • Central Nervous System Stimulants*
  • Conditioning, Classical / physiology*
  • Craving / physiology*
  • Cues*
  • Female
  • Heart Rate / physiology*
  • Humans
  • Male
  • Methamphetamine*
  • Psychotherapy / instrumentation
  • Psychotherapy / methods*
  • Virtual Reality

Substances

  • Central Nervous System Stimulants
  • Methamphetamine